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Abstract. Medical equipment (ME) is often considered to be an important factor in the 
growth of healthcare expenditures. In the Czech Republic (CR) validated approach does 
not yet exist for hospitals to use to assess commercial offers, nor is there a generally ac-
cepted methodology for regulatory bodies to allow for the evaluation of the effectiveness 
of prior purchases. This study intends to present a methodological approach that will allow 
for assessing the effectiveness of the procurement of capital ME based on international 
prices. The case of the purchase of tomotherapy system in the CR was used to demonstrate 
the developed approach. We performed a multiway search for international estimated and 
exact prices for tomotherapy unit using public-procurement databases, scientific papers, 
health technology assessment studies, professional reports, and Internet searches. All of 
the data that was gathered on prices was subjected to critical assessment vis-à-vis the 
reliability of the information. This research lays new methodology that may provide gen-
eral background of international comparison studies focused on ME. The results provide 
support for decision making about the acquisitions of ME.
Keywords: tomotherapy, medical equipment, price estimation, price comparison, acquisi-
tion, international comparison.
JEL Classification: I10, E31.
Introduction
Medical equipment is generally considered to be an important factor in the growth of 
health expenditures (for discussion, see Ivlev et al. 2014). According to the latest avai-
lable data, health spending is estimated to have increased by 1.0 percent in real terms 
across the OECD countries in 2013 (OECD 2015). Healthcare systems in the OECD 
countries thus face acute financial pressure; healthcare providers are responding to this 
pressure more and more by exploring every opportunity to increase efficiency and to 
reduce costs (Chilukuri et al. 2012; Gavurova, Soltes 2016; Soltes, Gavurova 2015; 
Maresova et al. 2016). 
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The number of large medical devices in the Czech Republic (CR) has increased gre-
atly over the last decade (IHIS 2013). For example, at the end of 2011 there were 155 
computed tomography scanners in the CR. Since 2001 the number of such devices per 
million inhabitants increased by 29 per cent, rising from 11.4 to 14.8. The number of 
magnetic resonance imaging (MRI) scanners gradually grew from 19 in 2001 to 72 in 
2011 (the number per million inhabitants increased from 1.9 in 2001 to 6.9 in 2011). 
In comparison with other Vysegrád group countries the CR is comparatively well equi-
pped with large medical devices such as diagnostic imaging technologies (Alexa et al. 
2015). Because large medical devices are usually not manufactured in the CR, they 
must be imported, either from within or outside the European Union (EU). Since the 
CR predominantly has a publicly funded healthcare system, both the purchase and re-
imbursement of these medical devices are mainly covered by public sources (e.g. public 
health insurance and public budgets). This implies the need for both the cost-effective 
use of public funding and the effective use of public procurements, where price is most 
important criterion (Roubinek et al. 2015). The previous decade was also characterized 
by the possibility of using EU structural funding to purchase new medical devices. 
Unfortunately, one aspect of the many purchases that have been made in the CR is 
the suspicion that these purchases have been overpriced in some cases (Transparency 
International – Czech Republic 2007). The Czech courts have examined a few of the 
purchases, after which several managers faced accusations related to their medical de-
vice purchases (e.g. Bachorík 2016). The Ministry of Finance of the CR (2014) also 
expressed doubts about the purchases of some of the devices that had been financed by 
EU structural funds. Another feature that may be observed in the field of medical device 
costs is that the doctors involved often have little or no idea how much medical devices 
cost (Okike et al. 2014), both in terms of purchases and operational costs.
The goal of this study is to suggest a possible approach for medical equipment price 
estimation based on international prices, as well as the approach’s utilization in the case 
of procurement of the first TomoTherapy® in the CR. General University Hospital in 
Prague was planning acquisition of the first tomotherapy system in CR since 2013. To-
motherapy equipment is one of the latest modalities in radiotherapy, in which irradiation 
is carried out by a helical tomotherapy technique (Van Dyk et al. 2002). The radiation 
source (linear accelerator) moves around the patient along a spiral trajectory using an 
on-board computed tomography (CT) scanner for imaging purposes. Tomotherapy equi-
pment can deliver better conformity of dose distribution in comparison with standard 
devices for 3D-conformal radiotherapy and intensity-modulated radiotherapy (Hsieh 
et al. 2012; Mesbah et al. 2011; NHSC 2006; Tsai et al. 2011). Tomotherapy units are 
suitable for the irradiation of a wide range of tumours from head to toe and, in certain 
cases, they can also be used for stereotactic irradiation (Ballini et al. 2010; Gerrity et al. 
2012; Ministry of Health Malaysia 2006; Van Dyk et al. 2002; Yartsev et al. 2007). 
1. Literature review
Prices for medical equipment differ around the world for many reasons, including di-
fferences in customs settings, market restrictions, and innovations, as well as further 
development of the devices or in the healthcare system itself (Szabo, Sidor 2014; Sol-
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tes, Gavurova 2014; Gavurova, Vagasova 2016). One important step during internati-
onal price comparisons involves the selection of comparable items. Drug products, for 
example, may be easily compared and identified using chemical formulas, although 
dissimilarities in package sizes between countries remains a problem (Andersson 1993). 
Medical equipment is characterized by a high level of technical complexity that creates 
variability in a number of components. In the case of sophisticated medical equipment 
such as CT or MRI devices, virtually no two similar devices exist; they may vary in 
terms of accessories and additional components, software and settings, installation loca-
tions, and the configuration of the place of operation. This situation makes any medical 
equipment purchase even more complicated to evaluate in terms of conducting price 
comparisons. The market for medical equipment within developed countries may almost 
be considered a business-to-business market, where prices are often negotiated. The 
result of such a market is that different buyers pay substantially different prices for the 
same product, even when it comes from the same supplier (Grennan 2013). 
International price comparisons for medical products are common within the health 
economics field (Danzon, Furukawa 2008; Hinsch et al. 2014; Simoens 2007; Vogler 
et al. 2015); reference pricing, however, is still very rare in the medical-devices sec-
tor (Sorenson, Kanavos 2011). Based on the empirical research and literature review 
we have conducted, we have identified several methodological issues in the process of 
conducting price estimations for medical equipment.
1.1. Information sources
The first step in this process is to gather information about medical equipment prices 
from other nations. Because final market prices are tend to be a commercial secret, the 
necessary data can be difficult to locate. Regardless of the information quality and reli-
ability (i.e., trustfulness), the researcher has to identify all available data that incorpo-
rates prices for the medical equipment model. It is possible to use different information 
sources, such as public-procurement databases, sales contracts (purchase orders), price 
quotes from sellers, price lists from manufacturers and distributors, scientific publica-
tions, health technology assessment (HTA) studies, reports from professional medical 
societies and other experts, and general news and Internet discussions. The information 
sources vary in terms of public availability, as well as reliability and temporal availability.
Public-procurement databases contain information about ongoing and completed ten-
ders. In the EU, for example, public organizations are governed by local public-procure-
ment acts. Specific types of tender-related information on such procurements have to 
be published in an EU-wide database known as the “Tenders Electronic Daily” (TED) 
database (European Union 2017). Among other data, TED database contains informa-
tion related to the results of public tenders: descriptions of purchased products, buyers, 
and suppliers; final achieved prices and related taxes. Due to the legislative basis of 
this information source, the reliability of the data may be considered to be quite high.
Some countries, including the CR, oblige certain public organizations to publish the 
results of any procurement above specified limits in the form of electronic copies of 
sales contracts. Sales contracts often contain more information than public-procurement 
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databases do, but finding and understanding the terms and conditions of contracts from 
other countries can be a challenge. Because such data does represent the real-world 
prices of medical equipment combined with contract terms and conditions, such sources 
thus need to be taken into account whenever they are available. Contracts that define 
future prices as an agreement between buyer and seller in which the conditions are set 
in place for the procurement of selected models for specified periods may also provide 
information about suggested future prices.
Scientific publications, HTA studies, and reports from professional medical societies and 
experts on medical equipment often contain data about acquisition costs. Although such 
prices represent the average costs for given models of medical equipment, the studies’ 
authors generally estimate the prices based on the available data; news gathered from 
hospital websites or other media may also contain information about medical equipment 
prices. News reports that acknowledge the purchase of medical equipment often include 
the whole capital costs of acquisition but do not specify further details. Such sources 
may be used as additional reference sources during the price-estimation process.
1.2. Country-specific data
For this study, we will reference the pricing information that we obtained from different 
countries with different settings. Diversity in healthcare-system models (e.g. Bismarck, 
Beveridge, National Health Insurance, Out-of-Pocket Models) or healthcare-facility type 
(private or public) both influence the way in which medical equipment is funded and 
procured and therefore affects final price (Graves 2011). Market characteristics – es-
pecially the level of competition between distributors – also affect procurement costs 
(Pammolli et al. 2005). Because the regulation of medical devices and related costs 
varies among different countries (Kaplan et al. 2004; Kramer et al. 2012; Sorenson, 
Drummond 2014), manufacturers and distributors may use these variances to adjust 
medical equipment prices. Another factor that affects the pricing of medical equipment 
is variations in taxes and import duties in different countries. 
The price levels for specific products also vary among different countries due to manu-
facturers’ pricing strategies. Deloitte’s study (2012), for instance, pointed out that many 
companies in the medical-devices market do not use global pricing contracts (i.e., one 
price for each product worldwide); instead, they are focused on local markets based on 
local demands, competition, and negotiation power.
To reduce possible errors during the gathering of international data, the comparison 
must focus on countries that are similar, within parameters related to equipment-funding 
types, market structure, and regulatory approach. We should point out, however, that 
differences in country-specific parameters are expected to affect the validity of such 
pricing data.
1.3. Limitations of price data
Various types of prices are available in the information sources mentioned above, in-
cluding list price, sale price, and others. While conducting research, it is necessary to 
determine the price that is appropriate for estimation purposes. The use of list pric-
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es may lead to overestimation of a medical device’s real price (Graboyes 1994). The 
healthcare sector, especially in the United States, is characterized by the widespread use 
of discounts that sellers provide to hospitals based on negotiations (Lerner 2010). As 
an example, the pricing list in the purchasing memorandum between New York State 
and one of the world largest manufacturers of medical equipment contains suggested 
net prices for diagnostic-imaging equipment that are 40 percent lower on average than 
the list prices (New York State Procurement). For these reasons, it is best to focus on 
the sale prices (i.e., the final prices in contracts) that were actually abided by within 
the acquisitions.
Medical equipment price may or may not include taxes, depending on the origin of the 
information source. The taxation systems and types of taxes (e.g., sales taxes or value-
added taxes [VAT]) that are applied to medical equipment differ around the world; for 
example, the standard VAT rate varies between 17 and 27 percent within the EU. For 
this reason, price comparisons must be provided in net-of-tax prices to avoid any pos-
sible discrepancies caused by different tax rates. The use of sources that are in any way 
unreliable could generate doubt about whether or not the price contains specific taxes. 
These kinds of situations must be resolved based on experts’ assumptions, which have 
to be clarified while conducting research.
Each final price may include separate components, such as the price of the item itself, 
the price of any additional components and accessories, user training and installation 
costs, software supplied with the equipment, shipping costs, additional services (i.e., 
maintenance), consumables, and others. Such price components for medical equipment 
may contain a significant part of the equipment’s total price. To cite two examples, one 
probe for a diagnostic ultrasound unit may represent 20 percent of the unit price itself, 
while prices for additional annual maintenance contracts for radiotherapy equipment are 
estimated to represent up to 10 percent of equipment costs (NICE 2014). These factors 
must be taken into account while conducting pricing analyses.
1.4. Temporal price conversion
Any pricing data that is collected may be related to different time periods. The difficulty 
in determining temporal price changes exists for all types of products and services, 
including new products and technologies that are widely introduced in the healthcare 
sector (Graboyes 1994). Different countries have developed individual pricing indices, 
each based on a predefined sector of products or services. The best-known index is 
the consumer price index (CPI), which is focused on a basket of products and services 
purchased by households. The healthcare market utilizes other price indices, such as the 
medical care price index, the personal healthcare expenditures deflator, and the national 
health expenditures deflator, to name a few. 
Some of the most commonly used price indices that may be used during the estimation 
of price of medical equipment include the following:
– Gross domestic product (GDP) deflator: a general measure of inflation.
– Consumer price index (CPI): a general price deflator from international statistical 
sources (e.g., OECD 2017a; World Bank 2017b) based on national CPIs as pub-
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lished by each country. This index could be stated for different commodities (all 
goods, food, energy, etc.).
– Harmonized index of consumer prices (HICP): a comparable measure of inflation 
in EU and other countries. This index is published by Eurostat (Eurostat 2017a); the 
index is available for a vast range of different commodities, including such groups 
of goods as “Medical products, appliances and equipment”.
Donahoe and King (2015) demonstrated that price indices for medical devices (for ex-
ample in the United States) are much lower than with other indices, such as the medical 
consumer price index or overall CPI. According to their analysis, the average annual 
rate for medical-device prices during the period 1989–2013 was relatively small: only 
0.9 percent. Prices for medical devices, however, are commonly discounted in economic 
analyses using CPIs for the given country (Brown et al. 2008; Brown et al. 2007a, 
2007b; Long et al. 2013). It is thus possible to use the CPI as an upper boundary for 
changes in pricing levels for medical devices.
Prices for healthcare technologies (i.e., medical devices) are also influenced by the 
effects of “experience curve,” where the price is related to total production volume 
(Brown et al. 2007b). Studies have shown that the experience curve for medical devices 
could follow a two-phase curve, and that the number of years since regulatory approval 
is the most significant factor in correlations with the experience-curve slope (Brown 
et al. 2008, 2007a). Brown et al. (2007a) also showed, however, that medical equipment 
(such as image-guided surgery hardware) experiences relatively lower price-decline 
rates than smaller medical devices such as stents or defibrillators. One possible reason 
for this is that medical devices are generally characterized by slower price-decline rates 
in the early stages of their lifecycles, possibly because of a lack of competition (Brown 
et al. 2007b). For the purposes of estimation, during the early stages of the lifecycle of 
a medical device it is thus possible to assume that unit price will be nearly stable and 
that the pricing trend will be affected by inflation.
1.5. Price conversion between countries
Prices vary not only temporally but also between countries due to different pricing 
levels -even among countries that use the same currency, such as Belgium and Portugal 
(Vachris, Thomas 1999). Several methods may be used to convert prices between dif-
ferent countries and currencies, such as international comparisons by fixed-exchange 
currency rates and the use of purchasing power parity (PPP) for conversion prices from 
one currency to another.
Conversion via official exchange rates is common in international price comparisons, 
although currencies’ exchange rates are influenced by other factors than simply the price 
level within different countries. Exchange rates do not reflect objective differences in 
prices between countries; the rates instead reflect a degree of interest in the currencies 
used in international markets. The official average exchange rates published by Eurostat 
or local central banks could be used for pricing estimation.
Another way to achieve pricing comparisons is to use PPP, which represents the number 
of units of a given national currency for which one can buy the same amount of goods 
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and services in the national market as a unit of another currency could purchase in an-
other market. This approach is standard for health-expenditures comparisons (Willemé, 
Dumont 2014). PPP is based on complex international comparison projects of differ-
ent consumer baskets. The OECD and Eurostat have conducted several studies in this 
field since the early 1980s to take the relative purchasing powers of the currencies of 
individual EU and OECD member countries into account. The OECD statistical data-
base provides data on general PPP for GDP on a regular basis (OECD 2017c). Eurostat 
provides a more detailed view of this indicator, including PPP for several aggregates, 
expenditure categories, and GDP groups (Eurostat 2017b). Detailed PPP data is avail-
able for the expenditure class “Electrical and optical equipment,” which covers medical 
equipment (OECD/Eurostat 2012).
1.6. Experts’ judgment
The final aggregation of processed data should lead to a formalized price estimation. 
Expert judgment is a common and acknowledged approach for generating price esti-
mates based on experts’ background, skills, and collected data related to the subject. In 
everyday life, expertise and decision-making are inseparably enmeshed. With the ex-
ception of purely psychomotor areas, we expect that widely identified experts will also 
make good judgments and decisions within their domain of expertise (Herbig, Glöckner 
2009). This approach makes it possible to carry out short-term estimations. In compari-
son to other estimation techniques (e.g., hedonic price estimation or knowledge-based 
systems), this approach requires relatively few resources in terms of time, cost, and data. 
A cost estimate is often needed before the procurement process begins. However, there 
is not enough time or space to develop complex deterministic or other pricing models 
for specified medical devices. 
The expert-judgment approach is used within the health sector for both clinical and 
nonclinical decision-making activities. When addressing difficult multidisciplinary prob-
lems such as the purchase of tomotherapy system, a combination of knowledge from 
several experts is required, especially from experts in various fields (Ivlev et al. 2015). 
This paper takes the knowledge summarized by Ivlev et al. (2015) into consideration; 
the goal is to conduct a complex assessment of the gathered data and to tap into various 
experts’ knowledge.
2. Methodology
Based on a comprehensive literature review, we used the following approaches for 
medical-equipment price estimation based on international prices in the case of tomo-
therapy system in the CR for General University Hospital in Prague in 2013.
We conducted a multiway (multifaceted) search for international estimated and exact 
prices of selected medical equipment. The TED database was used as the main informa-
tion source for exact prices (sale prices) in the EU. The keyword tomotherapy (and its 
translations into key European languages, such as tomothérapie in French or tomotera-
pia in Polish) was used for the search. 
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We then conducted a literature review in order to identify prices for tomotherapy equip-
ment in various countries; we limited the review to the following database systems: the 
Web of Science (WOS), ScienceDirect (Elsevier), SpringerLink, Wiley Online Library, 
PubMed, and Google Scholar. We used the keyword tomotherapy, and we included 
English-language studies in the review. We reviewed the full texts of papers to gather 
information about tomotherapy capital costs. 
In addition to previous results, we also investigated HTA studies and reports from 
professional medical societies and experts on medical equipment, including published 
reports and studies by organizations such as the ECRI Institute (USA), NICE (UK), 
EUnetHTA (EU), ISPOR (multiple countries), and others. Finally, we conducted a basic 
Internet search using the English, German and Italian translations of keywords such as 
tomotherapy, price, or cost. The Internet search focused on news articles about realized 
procurements of such equipment around the world, as well as on other professional 
reports that were not found during the previous search phase.
All of the data that was gathered on estimated prices was then subjected to critical as-
sessment in terms of reliability and the trustworthiness of information. We found the 
price information that we had obtained from HTA studies and professional reports to be 
reliable data for reference; we also considered news articles from hospital websites to 
be credible sources. Other data that had been gathered was subjected to detailed analy-
sis; in the case of significant risk of bias, this data was excluded from the study. Any 
potential uncertainties in the credibility of the source of the information were clearly set 
forth for further assessment. We analyzed the applicability (suitability) of the data we 
had gathered; this analysis focused on determining if purchased tomotherapy equipment 
corresponded to the objective. In other words, we analyzed the Tomotherapy model unit, 
as well as its accessories, terms, and the conditions of contractual and price components, 
in order to ensure the comparability of the price data that was included.
After conducting a critical assessment and exclusion of irrelevant and/or unreliable 
information, we performed an adjustment of temporally related national data. The pric-
ing data collected for each procurement was inflated according to the country of origin, 
based on inflation indices of credible international statistical organizations. For the pric-
ing data from EU member nations, we used the harmonized index of consumer prices 
(HICP) from Eurostat, and the index for category “Medical products, appliances and 
equipment” (Eurostat 2017a). For non-EU countries that are members of the OECD, we 
used the CPI from the OECD statistics and the index for items in the “non-food, non-
energy” category (OECD 2017b). For other countries, we used the GDP deflator from 
the World Bank (World Bank 2017a). The result of the adjustment was a broad range 
that represented the unification of these three estimates.
The price interval we obtained in the previous stage was then adjusted for national 
data so that we could make international comparisons. The collected price data for 
each procurement was adjusted according to the country of origin, based on (I) official 
exchange rates (CNB 2017) and (ii) PPP, based on Eurostat PPP data for electrical and 
optical equipment (Eurostat 2017b). 
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Finally, we located the adjusted price data in the form of price intervals for each pro-
curement; we then used this data in combination with the results of the critical as-
sessment of the information sources that had been provided to a panel of experts. The 
experts’ information, which was based on data they had received, their knowledge of 
market characteristics in the CR, and the demands of Czech purchasers (General Univer-
sity Hospital in Prague), was then used to estimate the proposed price range for capital 
costs of a tomotherapy unit within local conditions.
3. Results
According to the suggested methodology of the study, a search was conducted in the 
TED database for the procurement of tomotherapy units; the results are represented in 
Table 1. During our assessment of the applicability of the pricing data, we excluded 
the procurement by Azienda Ospedaliera Spedali Civili Di Brescia in Italy from 2011, 
because the final price included an additional eight-year service contract, and there was 
not enough data to separate the equipment price.
Table 1. Price information for tomotherapy units obtained from public-procurement databases
Year Country Buyer Currency Price without taxes Supplier
2013 France CHU de Martinique  
(CHU de Fort-de-France)
EUR 3 955 663 TomoTherapy 
Europe GmbH; Zug, 
Switzerland
2011 Italy Azienda Ospedaliero-
Universitaria Ospedali Riuniti 
EUR 4 113 000 Tecnologie Avanzate 
TA SRL; Turín, Italy
2011 Poland Centrum Onkologii-Instytut 
im. Marii Skłodowskiej-Curie 
Oddział w Gliwicach
PLN 15 740 602 EDO MED Sp.; 
Warsaw, Poland
2011 Italy Azienda Ospedaliera Spedali 
Civili Di Brescia*
EUR 14 371 200 Medipass SpA; 
Bologna, Italy
2011 Finland IS-Hankinta Oy EUR 3 210 000 Accuray Europe 
SAS; Paris, France
2010 France Assistance publique-Hôpitaux 
de Paris
EUR 3 256 710 TomoTherapy Inc.; 
Madison, WI, USA
Note: * Data excluded because the final price included an additional eight-year service contract and 
construction work; its data thus could not be separated from the price of the equipment. 
Source: authors’ own processing according to the TED database (European Union 2017).
Our systematic search within scientific papers was unable to identify information about 
tomotherapy equipment prices, which supports our statement that all information about 
final procurement prices remains hidden. During our search for HTA studies, profes-
sional reports, and news articles, we identified the estimated prices for tomotherapy 
units, as shown in Table 2.
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Table 2. Other data on estimated prices of tomotherapy units
Year Country Source Currency Price Type
2012 Italy (Giornale di Sicilia 2012) EUR 4 700 000 News
2012 Sri Lanka (DailyFT 2012) USD 3 725 000 News
2008 Italy (L’Azienda Ospedaliera 2008) EUR 3 500 000 News
2008 Singapore (Singapore Medicine 2008) USD 4 000 000 News
2007 USA (AUTM 2007) USD 3 500 000 Report
2006 UK (NHSC 2006) GBP 2 000 000 Report
2005 Australia (ANZHSN 2009) AUD 5 500 000 Report
Source: authors’ own processing based on literature review.
According to the suggested methodology of our study, we conducted three methods of 
inflation adjustment: (i) using the GDP deflator; (ii) adjustment for EU countries via 
HICP, and for other countries via general CPI; and (iii) adjustment for all countries via 
CPI. The result was a broad range that represents the unification of these three estimates.
Table 3. Inflation-adjusted prices for tomotherapy units from public-procurement databases
Inflation adjustment by Results




CPI CPI Min Max
2013 France EUR 3 955 663 – – – 3 955 663 3 955 663
2011 Italy EUR 4 113 000 4 173 079 4 277 520 4 231 360 4 173 079 4 277 520
2011 Poland PLN 15 639 862 16 070 393 16 385 596 16 234 701 16 070 393 16 385 596
2011 Finland EUR 3 210 000 3 291 720 3 297 485 3 311 674 3 291 720 3 311 674
2010 France EUR 3 256 710 3 340 989 3 236 304 3 327 043 3 236 304 3 340 989
Note: GDP deflator: complex inflation indicator (World Bank 2017a); HICP: harmonized index of 
consumer prices for category “Medical products, appliances and equipment” (Eurostat 2017a); CPI: 
Consumer prices index for category “non-food and non-energy” (OECD 2017b). Inflation adjustment 
for France 2013 was not carried out due to the year of acquisition.
Source: authors’ own calculations.
Table 4. Inflation adjustment of estimated prices for tomotherapy units
Inflation adjustment by Results
Year Country Cur. Price GDP deflator
HICP & 
CPI CPI Min Max
2012 Italy EUR 4 700 000 4 700 126 4 796 432 4 762 445 4 700 126 4 796 432
2012 Sri Lanka USD 3 725 000 3 725 065 – – 3 725 000 3 725 065
2008 Italy EUR 3 500 000 3 678 144 4 044 444 3 788 079 3 678 144 4 044 444
2008 Singapore USD 4 000 000 4 206 208 – – 4 000 000 4 206 208
2007 USA USD 3 500 000 3 794 256 3 883 699 3 883 699 3 794 256 3 883 699
2006 UK GBP 2 000 000 2 254 426 2 136 683 2 325 765 2 136 683 2 325 765
Note: GDP deflator: complex inflation indicator (World Bank 2017a); HICP: harmonized index of con-
sumer prices for category “Medical products, appliances and equipment” (Eurostat 2017a); CPI: Con-
sumer prices index for category “non-food and non-energy” (OECD 2017b). Conversion by HICP and 
CPI for Sri Lanka and Singapore was not carried out due to lack of official Eurostat and OECD data. 
Source: authors’ own calculations.
1203
Journal of Business Economics and Management, 2017, 18(6): 1193–1211
The two approaches were used to convert prices from other currencies into CZK: (i) by 
using official exchange rates (CNB 2017) and (ii) using PPP; this assessment was based 
on Eurostat PPP data for electrical and optical equipment (Eurostat 2017b).
Table 5. Conversion prices to CZK according to exchange rates and PPPs
Price in CZK
Inflation-adjusted price By exchange rate By PPP
Country Cur. Min Max Min Max Min Max
2013 
France EUR 3 955 663 3 955 663 100 770 507 102 625 712 100 698 827 100 698 827
2011 
Italy EUR 4 173 079 4 277 520 106 309 192 110 975 979 105 131 712 107 762 873
2011 
Poland PLN 16 070 393 16 385 596 95 565 553 102 784 860 99 595 069 101 548 513
2011 
Finland EUR 3 291 720 3 311 674 83 856 573 85 918 076 72 746 261 73 187 239
2010 
France EUR 3 236 304 3 340 989 82 444 838 86 678 616 82 386 194 85 051 151
Note: Maximum and minimum monthly average exchange rates of Czech National Bank (CNB) for 
2013 was applied (CNB 2017); PPP: purchasing power parity in “Electrical and optical equipment” 
for EU nations (Eurostat 2017b).
Source: authors’ own calculations.
Table 6. Conversion-estimated prices to CZK according to exchange rates and PPPs
Price in CZK
Inflation-adjusted price By exchange rate By PPP
Country Cur. Min Max Min Max Min Max
2012 
Italy EUR 4 700 126 4 796 432 119 735 706 124 438 626 118 409 514 120 835 733
2012 
Sri Lanka USD 3 725 000 3 725 065 71 034 041 74 547 277 – –
2008 
Italy EUR 3 678 144 4 044 444 93 700 721 104 929 067 92 662 892 101 891 038
2008 
Singapore USD 4 000 000 4 206 208 76 278 165 84 176 081 – –
2007 
USA USD 3 794 256 3 883 699 72 354 724 77 721 907 51 981 310 53 206 673
2006 
UK GBP 2 136 683 2 325 765 63 109 577 72 461 780 71 160 843 77 458 083
Note: Maximum and minimum monthly average exchange rates of CNB were applied (CNB 2017); 
PPP: purchasing power parity for category “Electrical and optical equipment” for EU nations (Eurostat 
2017b), and purchasing power parity for GDP for other countries (OECD 2017c). Conversion by PPP 
for Sri Lanka and Singapore was not carried out due to lack of official OECD data.
Source: authors’ own calculations.
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After the price conversion (adjustment for inflation and differences between countries), 
the price range for tomotherapy equipment for the CR was estimated to 115–125 million 
CZK (including VAT) and 95–103 million CZK (without VAT). The price range was 
estimated by experts based on adjusted price interval. The final price depended on the 
current CZK exchange rate and other factors (e.g., delivery for any construction work, 
technology licenses for computer stations, or picture archiving and communication sys-
tems [PACSs]). The estimated price does not include any design work or construction 
work for installing the system. The results of this study in unchanged form were submit-
ted to General University Hospital in Prague at the end of 2013; the procurement of the 
tomotherapy unit was realized by the same hospital in 2014. The acquisition price for 
the medical equipment (including installation, training, etc.) was roughly 121 million 
CZK including VAT, or 100.8 million CZK without VAT. The technical specifications, 
accessories, and purchase-contract parameters were all standard for this type of medical 
equipment in the CR. 
4. Discussion
Medical equipment is generally characterized by rapid improvements in functionality, 
performance, and safety. Changes in product quality or functionality extension are com-
monly not covered by price indices (Molina, Christian 2012; Strahl, Sobczak 2017). 
General price indices focus on consumer expenditures and do not include sales and 
excise taxes that are part of the price of goods. Industry-price indices that reflect the 
revenue a producer receives may also be used for price adjustments. The complication 
is that medical devices are sold in business-to-business markets, where the prices are 
often negotiated. This can result in different buyers paying substantially different prices 
for the same product, even when they come from the same supplier (Grennan 2013); 
price indices are not designed to work with this sort of system. It is also important to 
mention that our study covers hospitals in the CR that buy medical devices in CZK; 
limited evidence exists about the exchange that would occur if they received USD or 
euros from banks, and how they would negotiate such exchanges if they did receive 
such foreign currencies. 
The correction of differences in prices of medical devices between countries is more 
difficult to accomplish than when treating temporal differences. The discrepancies in 
pricing for medical devices between countries are caused by different price levels (Le-
rner 2010), even among countries that use the same currency (Vachris, Thomas 1999). 
Unlike the temporal point of view, which can be resolved by using different inflation 
rates, a comparison between countries is more difficult to accomplish. Several meth-
ods may be used for price conversion between different countries and currencies. For 
example, some researchers have conducted international price comparisons of medical-
device prices using fixed exchange rates (Ide et al. 2007; Kuroda et al. 2003); others 
have applied PPP to acquire conversion prices for medical devices from one currency 
to another (Simoens et al. 2009; Yasunaga et al. 2007). Different methods will generate 
different outcomes. Lorenzoni and Koechlin (2017) recently introduced the international 
comparison of health prices and newly its evaluation by volumes. They recommended 
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the use of health and hospital-specific price levels. Unfortunately, this approach was not 
focused on medical devices.
It is also important to emphasize that consulting experts’ decision-making processes 
to evaluate pricing information may also have limitations (Castellan 1993; Ivlev et al. 
2014, 2015; Rush, Rajkumar 2001). The application of experts’ judgments on pricing 
estimations is related to subjective assessment and thus is prone to bias. It is a common 
approach, however, when examining future medical equipment procurements.
Conclusions
In this research the main principles of the estimation of medical equipment prices based 
on international comparison was presented. This paper lays new methodology that can 
be generally used for future studies and may provide useful background of international 
comparison studies focused on ME. The proposed methodology allows the assessment 
of ME prices a can provide support for national and international decision making about 
the acquisitions of ME. Calculation have shown how this methodology can be applied 
in practice of different health care system regardless of the type of healthcare financing 
(both public and private).
Based on the new proposed methodology, we found that the prices of tomotherapy 
equipment in different countries varied by as much as +/– € 1 million, and that this also 
applies to countries that share the same currency. After price conversion (i.e., adjust-
ment for inflation and differences between countries), the price range for tomotherapy 
equipment for the CR was estimated to be 115–125 million CZK including VAT and 
95–103 million CZK without VAT. As of 2017, we know that the final purchase price 
of tomotherapy system was about 150 million CZK (€ 5.5 million), including the cost 
of construction work, and that the acquisition price for medical equipment (including 
installation, training, etc.) was roughly 121 million CZK with VAT, or 100.8 million 
CZK without VAT. The final price is in the range that we have described above, and 
therefore may be considered a reasonable price. The overall conclusion seems to be that 
suggested approach is appropriate for ME price estimation tasks.
Nevertheless, this study does suffer from some limitations. General price indices focus 
on consumer expenditures and do not include sales and excise taxes. Different methods 
of price correction between countries may generate different outcomes. Use of experts’ 
evaluation during decision-making processes may also have limitations.
Future research should tackle the identified limitations, especially price indexes and 
correction of price level between different countries. Finally, looking at another types 
of costly ME, would also be recommended.
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